What we do
Stemina is the world leader in building human cellular models for toxicity screening of drug candidates, chemical compounds, cosmetic and tobacco ingredients. Our developmental toxicity assays are the only human system for assessing the risk that a compound will cause birth defects if a woman is exposed during pregnancy.
MORE ABOUT US

What we do

Toxicology

Stemina's toxicology assays are the only human in vitro assays for developmental toxicity screening.

LEARN MORE

Technologies

Stemina's metabolomics platform and expertise in cellular models can be used for custom projects.

LEARN MORE

Our Team

Stemina has assembled a world class team of scientists and experts. Meet our team.

LEARN MORE

Latest news

Aug 16

Utilizing devTOXqP in a Combined Testing Approach for Identifying Developmental Toxicity Liability of Chemicals [Webinar Slides]

Aug 16, 2017
Why develop devTOX? Reduce prevalence of birth defects and decrease animal testing. Our approach represents a unique opportunity to screen compound safety using a human endpoint. devTOX quickPredict is a predictive, targeted biomarker assay. (devTOX Discovery, on the other hand, is a predictive, untargeted metabolomics assay.) Jessica Palmer presented this webinar in October 2016. If

Read more
Aug 16

Toward Good Read-Across Practice (GRAP) Guidance

Aug 16, 2017
Grouping of substances and utilizing read-across of data within those groups represents an important data gap filling technique for chemical safety assessments. Categories/analogue groups are typically developed based on structural similarity and, increasingly often, also on mechanistic (biological) similarity. While read-across can play a key role in complying with legislation such as the European REACH

Read more
Aug 16

Stem Cell-Based Methods for Identifying Developmental Toxicity Potential

Aug 16, 2017
There is an increasing need for reliable, high-throughput in vitro developmental toxicity screens in both the pharmaceutical and chemical industries. Establishing predictive human cell-based assays to aid in the early discovery-phase detection of potential developmental toxicants is strongly warranted as these tests could reduce product development time and costs. Stemina authors include Jessica Palmer, Bob

Read more